Add on therapy with hydrofluroalkane-beclomethasone (HFA-BDP) to an inhaled corticoidsteroid/long-acting beta-agonist (ICS/LABA) combination product to treat asthma: A retrospective study

Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2011
This article has no abstract
Epistemonikos ID: d9f013b2ab3a3a076b0a2ab1821600212322d05e
First added on: Feb 05, 2025